High OS, PFS and EFS with Low Rates of Rejection and GVHD after KIR-Favorable abCD3/CD19 Depleted Haploidentical HCT in Children with ALL/AML/MDS: Primary Analysis of the Pediatric Transplantation and Cellular Therapy Consortium ONC1401 Trial

Hisham Abdel‐Azim(University of Southern California), Mike A. Pulsipher(Primary Children's Hospital), Christopher C. Dvorak(University of California, San Francisco), Eric Anderson(Oregon Health & Science University), Carrie L. Kitko(Vanderbilt University Medical Center), Dimitri Monos(Children's Hospital of Philadelphia), Sonali Chaudhury(Northwestern University), Nahal Lalefar(University of California, San Francisco), Julie‐An Talano(Dana-Farber Cancer Institute), Leung Wing(KK Women's and Children's Hospital), Nancy Bunin(University of Iowa), Allyson Flower(New York Medical College), Kwang Woo Ahn(Medical College of Wisconsin)
Transplantation and Cellular Therapy
January 30, 2021
Cited by 0


Related Papers